Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Cymbalta (duloxetine) commonly causes nausea during the first 1–2 weeks of treatment. Most people find relief by taking it with food, starting at a lower dose, staying well hydrated, and timing doses consistently. This side effect is usually temporary and fades as your body adjusts, allowing you to benefit from Cymbalta's effects on nerve pain, depression, and anxiety.
Other key factors include natural remedies like ginger, watching for serious symptoms (severe vomiting, dehydration, or signs of serotonin syndrome), and planning carefully if discontinuing to avoid withdrawal effects.
Because nausea can also signal other underlying issues—or point to medication interactions worth reviewing—it's smart to clarify what's really driving your symptoms before adjusting anything. A free, instant, online symptom check can help you pinpoint likely causes, flag urgent warning signs, and guide your next steps with your doctor in just a few minutes.
Reviewed for medical accuracy: 07/03/2026
Burning or tingling feet? 30 seconds to find your next step.
Have you been diagnosed with diabetic neuropathy in your feet?
Cymbalta (duloxetine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) prescribed for chronic nerve pain, fibromyalgia, and other painful conditions. While many people find relief from symptoms like burning, tingling, or shooting pain, it's common to experience side effects—especially nausea—during the first few weeks. This guide explains why it happens, how to manage early discomfort, and when to seek medical advice.
Cymbalta works by increasing levels of serotonin and norepinephrine in the brain and spinal cord. These neurotransmitters help:
By targeting both nerve pain and mood, Cymbalta can offer dual benefits for people whose chronic pain has led to anxiety or low mood.
According to the U.S. Food and Drug Administration (FDA) prescribing information and peer-reviewed studies, the most frequent side effects include:
Among these, nausea is the most commonly reported during the first 1–2 weeks of treatment. Fortunately, it often subsides as your body adjusts.
Nausea with SNRIs like Cymbalta can result from:
Understanding that nausea is usually temporary can help set realistic expectations and reduce anxiety.
Most people tolerate Cymbalta better after the first few weeks. To minimize discomfort, consider these practical strategies:
Keep track of your symptoms. Most nausea should improve within 1–2 weeks. Contact your healthcare provider if you experience:
If you're concerned about any symptoms you're experiencing while on Cymbalta, you can quickly check your symptoms with Ubie's free AI-powered assessment tool to understand what might be happening and whether you should contact your doctor right away.
Understanding both the benefits and the possible discomforts helps you stay confident in your treatment plan. Most people find that:
Stay in close contact with your prescribing clinician to fine-tune your regimen.
Starting Cymbalta for nerve pain often means navigating initial side effects like nausea. By taking practical steps—such as adjusting when and how you take your medication, staying hydrated, and using gentle natural aids—you can reduce discomfort and focus on pain relief. Always monitor your symptoms and reach out if anything feels serious.
If you're unsure whether what you're experiencing is a normal side effect or something requiring immediate attention, use Ubie's AI symptom checker for a quick, personalized assessment that can help you decide your next steps.
And remember: if you experience severe or life-threatening symptoms, speak to a doctor right away. Your healthcare provider is your best resource for safe, effective pain management with Cymbalta.
(References)
* Stahl SM, et al. Strategies for managing duloxetine-related gastrointestinal adverse events. J Clin Psychiatry. 2010 Aug;71(8):1026-33. PMID: 20682333.
* Zimmerman M, et al. Management of Adverse Effects of Duloxetine: A Systematic Review. Prim Care Companion CNS Disord. 2015 Oct 15;17(5). PMID: 26978410.
* Pergolizzi JV Jr, et al. Duloxetine for chronic pain: a critical review of its efficacy and safety. Pain Ther. 2015 Dec;4(2):167-77. PMID: 26490604.
* Pérès K, et al. Adverse Drug Reactions to Duloxetine: A Retrospective Analysis of Individual Case Safety Reports from a French Pharmacovigilance Centre. Drug Saf. 2019 Jul;42(7):877-889. PMID: 30891047.
* Wu H, et al. Duloxetine in the management of neuropathic pain and chronic musculoskeletal pain: a review. Pain Ther. 2021 Sep;10(3):1091-1108. PMID: 34185191.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.